• Something wrong with this record ?

The effect of topiramate and lamotrigine on rat bone mass, structure and metabolism

J. Simko, S. Fekete, I. Gradosova, J. Malakova, H. Zivna, M. Valis, V. Palicka, P. Zivny,

. 2014 ; 340 (1-2) : 80-5.

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

There is only limited data concerning the effect of the newer antiepileptic drugs on bone. The objective of this study was to determine the effect of topiramate (TPM) and lamotrigine (LTG) monotherapy on bone mineral density (BMD), mineral content (BMC), bone markers, body composition and bone mechanical strength in the orchidectomized (ORX) rat model. 24 orchidectomized Wistar rats were divided into control and test groups, 8 rats in each group. The control rats received standard laboratory diet (SLD) while rats in the test group were fed with SLD enriched with LTG or TPM for 12 weeks. Dual energy X-ray absorptiometry was used to measure bone mineral density. The concentrations of bone metabolism markers were assayed in bone homogenate. In addition, both femurs were measured and used for biomechanical testing. Compared to the control group, both test groups had significantly lower weight, fat mass, whole body and femur BMD, BMC and reduced mechanical strength of bone. All of these changes were more pronounced in rats exposed to LTG. In conclusion, both LTG and TPM significantly reduce BMD and body weight and impair mechanical strength of bone. A question arises as to the degree of dependence of the effect on the dose. Further studies are warranted to establish whether LTG and TPM may have a clinically significant effect on BMD exclusively in the model of gonadectomized rats, or whether the effect applies also in the model of gonadally intact animals, and in the respective human models.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008192
003      
CZ-PrNML
005      
20150330114417.0
007      
ta
008      
150306s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jns.2014.02.032 $2 doi
035    __
$a (PubMed)24629477
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Simko, Julius $u Department of Neurology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Czech Republic. Electronic address: simko.julius@gmail.com.
245    14
$a The effect of topiramate and lamotrigine on rat bone mass, structure and metabolism / $c J. Simko, S. Fekete, I. Gradosova, J. Malakova, H. Zivna, M. Valis, V. Palicka, P. Zivny,
520    9_
$a There is only limited data concerning the effect of the newer antiepileptic drugs on bone. The objective of this study was to determine the effect of topiramate (TPM) and lamotrigine (LTG) monotherapy on bone mineral density (BMD), mineral content (BMC), bone markers, body composition and bone mechanical strength in the orchidectomized (ORX) rat model. 24 orchidectomized Wistar rats were divided into control and test groups, 8 rats in each group. The control rats received standard laboratory diet (SLD) while rats in the test group were fed with SLD enriched with LTG or TPM for 12 weeks. Dual energy X-ray absorptiometry was used to measure bone mineral density. The concentrations of bone metabolism markers were assayed in bone homogenate. In addition, both femurs were measured and used for biomechanical testing. Compared to the control group, both test groups had significantly lower weight, fat mass, whole body and femur BMD, BMC and reduced mechanical strength of bone. All of these changes were more pronounced in rats exposed to LTG. In conclusion, both LTG and TPM significantly reduce BMD and body weight and impair mechanical strength of bone. A question arises as to the degree of dependence of the effect on the dose. Further studies are warranted to establish whether LTG and TPM may have a clinically significant effect on BMD exclusively in the model of gonadectomized rats, or whether the effect applies also in the model of gonadally intact animals, and in the respective human models.
650    _2
$a absorpční fotometrie $7 D015502
650    _2
$a aplikace orální $7 D000284
650    _2
$a alkalická fosfatasa $x metabolismus $7 D000469
650    _2
$a zvířata $7 D000818
650    _2
$a antikonvulziva $x aplikace a dávkování $7 D000927
650    _2
$a biomechanika $x účinky léků $7 D001696
650    _2
$a složení těla $x účinky léků $7 D001823
650    _2
$a tělesná hmotnost $x účinky léků $7 D001835
650    _2
$a kostní denzita $x účinky léků $7 D015519
650    _2
$a kostní morfogenetický protein 2 $x metabolismus $7 D055396
650    _2
$a kosti a kostní tkáň $x účinky léků $x metabolismus $7 D001842
650    _2
$a kolagen typu I $x metabolismus $7 D024042
650    _2
$a ELISA $7 D004797
650    _2
$a fruktosa $x analogy a deriváty $x farmakologie $7 D005632
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a modely u zvířat $7 D023421
650    _2
$a orchiektomie $7 D009919
650    _2
$a osteoprotegerin $x krev $7 D053244
650    _2
$a peptidové fragmenty $x metabolismus $7 D010446
650    _2
$a peptidy $x metabolismus $7 D010455
650    _2
$a prokolagen $x metabolismus $7 D011347
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a neparametrická statistika $7 D018709
650    _2
$a triaziny $x aplikace a dávkování $7 D014227
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fekete, Sona $u Institute of Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Czech Republic.
700    1_
$a Gradosova, Iveta $u Institute of Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Czech Republic.
700    1_
$a Malakova, Jana $u Institute of Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Czech Republic.
700    1_
$a Zivna, Helena $u Radioisotope Laboratories and Vivarium, Charles University in Prague, Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czech Republic.
700    1_
$a Valis, Martin $u Department of Neurology, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Czech Republic.
700    1_
$a Palicka, Vladimir $u Institute of Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Czech Republic.
700    1_
$a Zivny, Pavel $u Institute of Clinical Biochemistry and Diagnostics, Charles University in Prague, Faculty of Medicine and University Hospital in Hradec Kralove, Czech Republic.
773    0_
$w MED00003004 $t Journal of the neurological sciences $x 1878-5883 $g Roč. 340, č. 1-2 (2014), s. 80-5
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24629477 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150330114646 $b ABA008
999    __
$a ok $b bmc $g 1065465 $s 890992
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 340 $c 1-2 $d 80-5 $i 1878-5883 $m Journal of the neurological sciences $n J Neurol Sci $x MED00003004
LZP    __
$a Pubmed-20150306

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...